Dominik Pfister

Department of Chronic Inflammation and Cancer -Coordination and communication of collaborations for mouse/patient data -Managing of technical assistants (1-3) and mouse permits -Preparation (4x) and finalization of 2x publications; reviewer for Journal “Cancers” -presentation of scientific data -Responsible for introduction, maintenance and panel design for the Department`s flow cytometer (LSRFortessa) -Characterization of NASH mouse models by FACS, IHC and basic molecular biology

-Managing of permits for animal experiments -Supervision of Master student -Finalization of two publications; speaker at EASL 2019, Vienna -Responsible for user introduction, maintenance and panel design for the Department`s flow cytometer (LSRFortessa) -Characterization of coagulation and checkpoint inhibition in mouse models of non-alcoholic steatohepatitis combining flow cytometry, immunohistochemistry, basic molecular biology and ultrasound based in vivo imaging

-Managing of mouse cohorts -Molecular biological characterization of non-alcoholic steatohepatitis by flow cytometry, Western blot, qPCR and biochemical assays -Hybridoma based production of antibodies for in vivo application

-P53 mutation analysis by Sanger sequencing of patient material, contribution to one publication -Immunohistochemical stainings production -Organization of patient information

-Learning Selex cycles and biochemical methods for construction of bi-specific streptavidin/his-tag aptamers

Major subject: Proteinbiochemistry; Minor subject: Pharmacology and Toxikology Master thesis: Effect of functionalized superparamagnetic hybrid nanomaterials on cancer cells; Institute of Natural Products and Clinical Pharmacology, Ulm University, Germany

Bachelor thesis: Biochemical construction of a bispecific Streptavidin/His-Tag aptamer; Institute of Pharmaceutical Biotechnology, Ulm University, Germany